Home > Journals > China Journal of Chinese Materia Medica >Issue 07,2020
China Journal of Chinese Materia Medica
Translated from the Chinese edition
Supervisor(s): China Association for Science and Technology
Sponsor(s): Institute of Chinese Pharmaceutical Association
CN:11-2272/R

24 issues per year

Current Issue: Issue 07, 2020  

Total Downloads:1216

Journal official website:http://zgzye.cbpt.cnki.net/WKE/WebPublication/index.aspx?mid=zgzye

  • China Journal of Chinese Materia Medica, the 1st in the field of TCM, is supervised by China Association for Science and Technology and sponsored by Institute of Chinese Pharmaceutical Association. The journal is China's earliest comprehensive core journal of traditional Chinese medicine, and always maintains the circulation top in the professional areas. The journal publishes the latest research and progress of traditional Chinese medicine and takes a leading position in numbers of articles published, downloads and citations among all journals in this discipline. Its scope covers new achievements, technologies, methods, experiences and concepts resulting from the research on Chinese materia medica pursuant to Chinese medical and pharmaceutical theories, traditional experiences, and modern science and technology, including medicinal resources and identification, cultivation, processing, preparation, chemistry, pharmacology, theory of Chinese pharmacy and clinical practice, bencaological study. The journal is included in CA, JST and CSCD.

  • Honorary Editor-in-Chief
    Xiao Peigen
    Editor-in-Chief
    Wang Yongyan

    Associate Editors
    Zhang Boli, Hu Zhibi, Yao Xinsheng, Li Lianda, Li Dapeng, Yang Baofeng, Zhou Chaofan, Huang Luqi, Chen Shilin, Li He.

    Executive Editorial Board
    Cai Shaoqing, Chen Shilin

Characterization of AOX family members from Aquilaria sinensis and their responses to wounding

LIU Pei-wei;LYU Fei-fei;ZHANG Yu-xiu;YANG Yun;GAO Zhi-hui;LIANG Hui-hui;WEI Jian-he

China Journal of Chinese Materia Medica,2020,Vol 45,No. 07

Qualitative and quantitative research on nucleosides of Rhizoma Alismatis from different regions

LIU Shan-shan;LIU Xiao-qian;TIAN Shuang-shuang;ZHU Jing-jing;GAO Hui-min;YAN Li-hua;WANG Zhi-min;GAO Lu

China Journal of Chinese Materia Medica,2020,Vol 45,No. 07

Bioinformatic analysis of differentially expressed genes and Chinese medicine prediction for ulcerative colitis

HU Zong-ren;ZHENG Wen-jiang;YAN Qian;HU Wei-wei;SUN Xiao-sheng

China Journal of Chinese Materia Medica,2020,Vol 45,No. 07

Recommendations on quality standards of Alismatis Rhizoma in Chinese Pharmacopoeia(2020 edition)

ZHAO Xiao-mei;TIAN Shuang-shuang;LIU Shan-shan;QU Qian;ZHAO Jing-yuan;YAN Li-hua;WANG Zhi-min

China Journal of Chinese Materia Medica,2020,Vol 45,No. 07

Grade evaluation of Sophorae Tonkinensis Radix et Rhizoma based on quality constant evaluation method

ZHAO An-yi;LIU Yan;SHI Jia;NI Feng-yan;LIU An;ZHANG Ai-ping

China Journal of Chinese Materia Medica,2020,Vol 45,No. 07

Preparation and in vitro release of ginkgolide B nanosuspension

WANG Jing;ZHU Jun-jun;SHEN Bao-de;ZHANG Ting;ZHU Ya-ning;YUAN Hai-long

China Journal of Chinese Materia Medica,2020,Vol 45,No. 07

Regional differences analysis of Alismatis Rhizoma based on UPLC characteristic chromatogram and determination of eight terpenoids

TIAN Shuang-shuang;ZHAO Xiao-mei;LIU Shan-shan;FENG Wei-hong;CHEN Liang-mian;YAN Li-hua;WANG Zhi-min

China Journal of Chinese Materia Medica,2020,Vol 45,No. 07